MHC-dependent antigen processing and peptide presentation: Providing ligands for T lymphocyte activation
暂无分享,去创建一个
[1] J. Bonifacino,et al. Association with BiP and aggregation of class II MHC molecules synthesized in the absence of invariant chain. , 1994, The EMBO journal.
[2] A. Goldberg,et al. Gamma-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. , 1993, Nature.
[3] D. Finley,et al. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome , 1993, Nature.
[4] S. Tonegawa,et al. TAP1-dependent peptide translocation in vitro is ATP dependent and peptide selective , 1993, Cell.
[5] J. Neefjes,et al. Selective and ATP-dependent translocation of peptides by the MHC-encoded transporter. , 1993, Science.
[6] F. Sinigaglia,et al. Promiscuous and allele-specific anchors in HLA-DR-binding peptides , 1993, Cell.
[7] D. Wiley,et al. Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 , 1993, Nature.
[8] R. Germain,et al. Peptide binding inhibits protein aggregation of invariant-chain free class II dimers and promotes surface expression of occupied molecules , 1993, Nature.
[9] K. Rock,et al. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[10] R. Germain,et al. Defective major histocompatibility complex class II assembly, transport, peptide acquisition, and CD4+ T cell selection in mice lacking invariant chain expression , 1993, The Journal of experimental medicine.
[11] R. Germain,et al. Peptide-major histocompatibility complex class II complexes with mixed agonist/antagonist properties provide evidence for ligand-related differences in T cell receptor-dependent intracellular signaling , 1993, The Journal of experimental medicine.
[12] J. Yewdell,et al. Relationship between invariant chain expression and major histocompatibility complex class II transport into early and late endocytic compartments , 1993, The Journal of experimental medicine.
[13] C. Benoist,et al. Mice lacking the MHC class II-associated invariant chain , 1993, Cell.
[14] J. Pfeifer,et al. Phagocytic processing of bacterial antigens for class I MHC presentation to T cells , 1993, Nature.
[15] R. Germain,et al. The biochemistry and cell biology of antigen processing and presentation. , 1993, Annual review of immunology.
[16] A. Miller,et al. Dominance and crypticity of T cell antigenic determinants. , 1993, Annual review of immunology.
[17] P. Cresswell,et al. HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides , 1992, Nature.
[18] William S. Lane,et al. Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle , 1992, Nature.
[19] P. Cresswell,et al. Proteasome subunits encoded in the MHC are not generally required for the processing of peptides bound by MHC class I molecules , 1992, Nature.
[20] J. Neefjes,et al. Proteasome subunits encoded by the major histocompatibility complex are not essential for antigen presentation , 1992, Nature.
[21] H. Geuze,et al. Class II MHC molecules are present in macrophage lysosomes and phagolysosomes that function in the phagocytic processing of Listeria monocytogenes for presentation to T cells , 1992, The Journal of cell biology.
[22] Dean R. Madden,et al. The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC , 1992, Cell.
[23] W. T. Schaiff,et al. HLA-DR associates with specific stress proteins and is retained in the endoplasmic reticulum in invariant chain negative cells , 1992, The Journal of experimental medicine.
[24] William S. Lane,et al. Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size , 1992, Nature.
[25] P. A. Peterson,et al. Emerging principles for the recognition of peptide antigens by MHC class I molecules. , 1992, Science.
[26] E. Bikoff. Formation of complexes between self-peptides and MHC class II molecules in cells defective for presentation of exogenous protein antigens. , 1992, Journal of immunology.
[27] A Sette,et al. Peptides presented to the immune system by the murine class II major histocompatibility complex molecule I-Ad. , 1992, Science.
[28] Eric O Long,et al. Processing pathways for presentation of cytosolic antigen to MHC class II-restricted T cells , 1992, Nature.
[29] A. Goldberg,et al. Proteolysis, proteasomes and antigen presentation , 1992, Nature.
[30] E. Degen,et al. Efficient dissociation of the p88 chaperone from major histocompatibility complex class I molecules requires both beta 2- microglobulin and peptide , 1992, The Journal of experimental medicine.
[31] J. Slot,et al. Location of MHC-encoded transporters in the endoplasmic reticulum and cis-Golgi , 1992, Nature.
[32] N. Huskisson,et al. Effect of polymorphism of an MHC-linked transporter on the peptides assembled in a class I molecule , 1992, Nature.
[33] F. Maxfield,et al. Delivery of ligands from sorting endosomes to late endosomes occurs by maturation of sorting endosomes , 1992, The Journal of cell biology.
[34] M. Anderson,et al. Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[35] R. Henderson,et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. , 1992, Science.
[36] H. Grey,et al. Antigen analog-major histocompatibility complexes act as antagonists of the T cell receptor , 1992, Cell.
[37] J. Monaco. Genes in the MHC that may affect antigen processing , 1992, Current Biology.
[38] A. Rudensky,et al. Sequence analysis of peptides bound to MHC class II molecules , 1991, Nature.
[39] A. Lanzavecchia,et al. Processed antigen binds to newly synthesized mhc class II molecules in antigen-specific B lymphocytes , 1991, Cell.
[40] R. Germain,et al. MHC class II structure, occupancy and surface expression determined by post-endoplasmic reticulum antigen binding , 1991, Nature.
[41] P. Allen,et al. Separation of IL-4 production from Th cell proliferation by an altered T cell receptor ligand. , 1991, Science.
[42] H. Rammensee,et al. Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules , 1991, Nature.
[43] D. Wiley,et al. Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. , 1991, Journal of molecular biology.
[44] W R Taylor,et al. A hypothetical model for the peptide binding domain of hsp70 based on the peptide binding domain of HLA. , 1991, The EMBO journal.
[45] R. Germain,et al. Invariant chain promotes egress of poorly expressed, haplotype-mismatched class II major histocompatibility complex A alpha A beta dimers from the endoplasmic reticulum/cis-Golgi compartment. , 1991, Proceedings of the National Academy of Sciences of the United States of America.
[46] S. Weiss,et al. MHC class II—Restricted presentation of intracellular antigen , 1991, Cell.
[47] H. Geuze,et al. Segregation of MHC class II molecules from MHC class I molecules in the Golgi complex for transport to lysosomal compartments , 1991, Nature.
[48] F. Brodsky,et al. The cell biology of antigen processing and presentation. , 1991, Annual review of immunology.
[49] R. Steinman,et al. The dendritic cell system and its role in immunogenicity. , 1991, Annual review of immunology.
[50] T. Olson,et al. Targeting specific proteins for lysosomal proteolysis. , 1991, Biomedica biochimica acta.
[51] P. A. Peterson,et al. Intracellular transport of class II MHC molecules directed by invariant chain , 1990, Nature.
[52] P. A. Peterson,et al. Invariant chain distinguishes between the exogenous and endogenous antigen presentation pathways , 1990, Nature.
[53] P. Cresswell,et al. Intracellular transport and peptide binding properties of HLA class II glycoproteins. , 1990, Seminars in immunology.
[54] P. Cresswell,et al. Invariant chain association with HLA-DR molecules inhibits immunogenic peptide binding , 1990, Nature.
[55] M. Cohn,et al. The Protection: The Unit of Humoral Immunity Selected by Evolution , 1990, Immunological reviews.
[56] P. Jensen,et al. Regulation of antigen presentation by acidic pH , 1990, The Journal of experimental medicine.
[57] Joseph Schlessinger,et al. Signal transduction by receptors with tyrosine kinase activity , 1990, Cell.
[58] M. Bevan,et al. Class I-restricted processing and presentation of exogenous cell- associated antigen in vivo , 1990, The Journal of experimental medicine.
[59] M. A. Saper,et al. Specificity pockets for the side chains of peptide antigens in HLA-Aw68 , 1990, Nature.
[60] L Adorini,et al. Capacity of intact proteins to bind to MHC class II molecules. , 1989, Journal of immunology.
[61] H. Ljunggren,et al. Association of class I major histocompatibility heavy and light chains induced by viral peptides , 1989, Nature.
[62] R. Schwartz. Acquisition of immunologic self-tolerance , 1989, Cell.
[63] C. Janeway,et al. Cross-linking and conformational change in T-cell receptors: role in activation and in repertoire selection. , 1989, Cold Spring Harbor symposia on quantitative biology.
[64] M. Bevan,et al. Introduction of soluble protein into the class I pathway of antigen processing and presentation , 1988, Cell.
[65] P. Cresswell,et al. Role for intracellular proteases in the processing and transport of class II HLA antigens. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[66] F Celada,et al. Differential activation of T cell clones stimulated by macrophages exposed to antigen complexed with monoclonal antibodies. A possible influence of paratope specificity on the mode of antigen processing. , 1988, Journal of immunology.
[67] J. Yewdell,et al. Cells process exogenous proteins for recognition by cytotoxic T lymphocytes. , 1988, Science.
[68] M. A. Saper,et al. Structure of the human class I histocompatibility antigen, HLA-A2 , 1987, Nature.
[69] J. Berzofsky,et al. Antibody conjugates mimic specific B cell presentation of antigen: relationship between T and B cell specificity. , 1987, Journal of immunology.
[70] M. Bevan. Class discrimination in the world of immunology , 1987, Nature.
[71] R. Germain. Immunology: The ins and outs of antigen processing and presentations , 1986, Nature.
[72] T. Braciale,et al. Differences in antigen presentation to MHC class I-and class II- restricted influenza virus-specific cytolytic T lymphocyte clones , 1986, The Journal of experimental medicine.
[73] P. Cresswell. Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[74] K. Rock,et al. Antigen presentation by hapten-specific B lymphocytes. II. Specificity and properties of antigen-presenting B lymphocytes, and function of immunoglobulin receptors. , 1985, Journal of immunology.
[75] J. Davey,et al. Cytotoxic T cells recognize fragments of the influenza nucleoprotein , 1985, Cell.
[76] Antonio Lanzavecchia,et al. Antigen-specific interaction between T and B cells , 1985, Nature.
[77] R. Schwartz. T-lymphocyte recognition of antigen in association with gene products of the major histocompatibility complex. , 1985, Annual review of immunology.
[78] H. Mcdevitt,et al. Histocompatibility-linked immune response genes. , 1972, Science.
[79] N. Klinman. THE MECHANISM OF ANTIGENIC STIMULATION OF PRIMARY AND SECONDARY CLONAL PRECURSOR CELLS , 1972, The Journal of experimental medicine.
[80] R. Barth,et al. Strong and Weak Histocompatibility Gene Differences in Mice and Their Role in the Rejection of Homografts of Tumors and Skin , 1956, Annals of surgery.